Effect of Excision of the Infrapatellar Fat Pad in Total Knee Arthroplasty: A Double-Blinded Randomized Controlled Trial
In brief
Knee fat-pad removal does not improve pain or function at two years
In this randomized trial, patients whose fat pad was removed had no significant difference in pain or function at two years compared with those whose fat pad was mostly retained; both groups improved after knee replacement. Results were based on 140 of 181 participants, with 22% lost to follow-up, so larger studies could clarify whether the groups differ.
- Journal
- The Journal of arthroplasty (Q1)
- Published
- 13 November 2026
- Study design
- Randomized controlled trial
- Evidence level
- Level 1, High (CEBM 1b)
- Authors
- A Howard, H Naeem, A Wood, A Santini, J Davidson, A Phillipson, et al.
- PMID
- 43025520
- DOI
- 10.1016/j.arth.2026.11.008
Why clinicians should know about it
- Picked for Orthopedics and Sports Medicine (top studies of the week, 15 November 2026): Randomized trial informs technique during total knee arthroplasty
Abstract
BACKGROUND: The infrapatellar (Hoffa's) fat pad is frequently excised during total knee arthroplasty (TKA) to improve exposure, but its role in postoperative pain and function is uncertain. Previous randomized trials and meta-analyses are equivocal, with follow-up limited to 12 months. METHODS: We conducted a single-center, participant- and assessor-blinded, parallel-group randomized controlled trial. A total of 181 patients undergoing elective primary TKA for osteoarthritis were randomized intraoperatively to fat pad excision (removed) or minimal resection (retained). Implants and rehabilitation were standardized. The primary outcome was the Knee injury and Osteoarthritis Outcome Score (KOOS) at 24 months; the secondary outcome was the Oxford Knee Score (OKS) at three, 12, and 24 months. Groups were compared using Mann-Whitney U-tests, and within-group changes over time using Kruskal-Wallis tests. In total, 140 participants were analyzed at 24 months (74 removed, 66 retained; 22% loss to follow-up). RESULTS: Both groups improved significantly across all KOOS subscales and OKS over time (P-values < 0.05), with gains exceeding the minimal clinically important difference on KOOS Pain. There were no significant between-group differences in KOOS or OKS at any time point (P-values > 0.05). The only within-group gain unique to one arm was KOOS Symptoms in the removed group between three and 24 months (P-values < 0.05). The KOOS scores did not improve between 12 and 24 months. CONCLUSION: In this study, excision or preservation of the fat pad did not significantly influence pain or function at two years postoperatively. The absence of change beyond 12 months suggests future trials could shorten follow-up.
Abstract as published, via PubMed.
For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.